Researcher
An Coosemans
- Disciplines:Cancer therapy, Cancer biology, Neurosurgery
Affiliations
- Laboratory for Tumor Immunology and Immunotherapy (Division)
Responsible
From1 Oct 2019 → Today - Laboratory for Tumor Immunology and Immunotherapy (Division)
Member
From1 Sep 2016 → Today - Gynaecological Oncology (Division)
Member
From1 Oct 2013 → 31 Aug 2016 - Allergy and Clinical Immunology Research Group (Division)
Member
From1 Oct 2012 → 30 Sep 2013
Projects
1 - 10 of 18
- Development of tumor-derived dendritic cell therapies to prevent ovarian cancer metastasisFrom13 Nov 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- How to deal with recurrent ovarian cancer: a new approach.From1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Developing combinatorial immunotherapy for glioblastomaFrom7 Nov 2022 → TodayFunding: Foundations, funds and other with scientific goal
- Next-generation, multi-technology immune-monitoring and easy-access spectral flow cytometryFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- DIPITO: valorisation of deep immune profiling and novel immunotherapeutics for oncology.From1 Oct 2021 → TodayFunding: IOF - mandates
- Preclinical evaluation of novel radionuclide therapies in different cancer modelsFrom8 Jul 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Deciphering the dendritic cell compartment in ovarian cancer to assess their potential as tumor vaccines.From1 Jan 2021 → TodayFunding: FWO research project (including WEAVE projects)
- Spectral flowcytometry (Cytek Aurora)From1 Jan 2021 → 31 Dec 2022Funding: BOF - scientific equipment program
- Deciphering the dendritic cell compartment in ovarian cancer to assess their potential as tumor vaccinesFrom8 Oct 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Rational approach for immunotherapy in ovarian cancer.From1 Sep 2020 → TodayFunding: Foundations, funds and other with scientific goal
Publications
1 - 10 of 113
- Comparison of the ADNEX and ROMA risk prediction models for the diagnosis of ovarian cancer: a multicentre external validation in patients who underwent surgery(2024)
Authors: Jolien Ceusters, Wouter Froyman, Toon Van Gorp, Ruben Heremans, Thaïs Baert, Roxanne Wouters, Anne-Sophie Van Rompuy, An Coosemans, Dirk Timmerman, Ben Van Calster
- TIM3 Checkpoint Inhibition Fails to Prolong Survival in Ovarian Cancer-Bearing Mice.(2024)
Authors: Yani Berckmans, Jolien Ceusters, Ignace Vergote, An Coosemans
Pages: 1147 - Image-based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno-oncology Biomarker Working Group on Breast Cancer(2024)
Authors: Sara Verbandt, An Coosemans, Sabine Tejpar
- Toward more accurate preclinical glioblastoma modeling: Reverse translation of clinical standard of care in a glioblastoma mouse model.(2024)
Authors: Yani Berckmans, Kim De Keersmaecker, An Coosemans
Pages: 381 - 397 - A Microfluidics Approach for Ovarian Cancer Immune Monitoring in an Outpatient Setting.(2024)
Authors: Ann Vankerckhoven, Thaïs Baert, Toon Van Gorp, An Coosemans, Liesbet Lagae
- Trial watch: chemotherapy-induced immunogenic cell death in oncology(2023)
Authors: Jenny Sprooten, Isaure Vanmeerbeek, Stefan Naulaerts, Lisa Kinget, An Coosemans, Steven De Vleeschouwer, Els Wauters, Sabine Tejpar, Benoit Beuselinck, Sigrid Hatse, et al.
- Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: a report of the international immuno-oncology biomarker working group(2023)
Authors: Sara Verbandt, An Coosemans, Sabine Tejpar
Pages: 498 - 513 - Spatial analyses of immune cell infiltration in cancer: current methods and future directions. A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer(2023)
Authors: Sara Verbandt, An Coosemans, Sabine Tejpar
Pages: 514 - 532 - Drug Repurposing for Targeting Myeloid-Derived Suppressor-Cell-Generated Immunosuppression in Ovarian Cancer: A Literature Review of Potential Candidates(2023)
Authors: Yani Berckmans, Yannick Hoffert, Erwin Dreesen, An Coosemans
- Radiation dose-escalation and dose-fractionation modulate the immune microenvironment, cancer stem cells and vasculature in experimental high-grade gliomas(2023)
Authors: Matteo Riva, Roxanne Wouters, David Nittner, Jolien Ceusters, Edmond Sterpin, Uwe Himmelreich, Willy Gsell, Marc Van Ranst, An Coosemans
Pages: 55 - 65
Patents
1 - 4 of 4
Linked dataset
1 - 1 of 1